Priya Rao, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 26 years
- Graduated 2000
Offices
4 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rao’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington MDRE.ML.20008379Physician And Surgeon Residency Limited License · since 2005 · expires 2009-06-15ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$1,720
Medicare paid this office $1,720 for 15 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 77 · Health risk score 2.04. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75%.
The office billed $4,847, Medicare allowed $2,252 and paid $1,720; for 23 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 15 | 23 | 77 | 2.04 | $4,847 | $1,720 |
| 2023 | 24 | 42 | 66 | 2.34 | $7,575 | $3,293 |
| 2021 | 11 | 40 | 75 | 2.91 | $6,581 | $2,635 |
| 2018 | 28 | 47 | 73 | 3.35 | $9,752 | $3,283 |
| 2017 | 31 | 91 | 72 | 2.75 | $17,406 | $5,768 |
| 2016 | 26 | 51 | 73 | 3.30 | $12,452 | $3,458 |
| 2015 | 27 | 58 | 75 | 2.25 | $13,685 | $3,847 |
| 2014 | 18 | 40 | 71 | 2.87 | $10,052 | $2,989 |
| 2013 | 34 | 70 | 71 | 2.92 | $18,345 | $5,159 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,854 | $71 |
2018: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,506 | $63 |
2017: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $3,203 | $60 |
| Hospital discharge day management, 30 minutes or less | 12 | $729 | $61 |
2015: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,705 | $63 |
2013: 1 service
| Hospital discharge day management, 30 minutes or less | 14 | $834 | $60 |
Drugs they prescribed that Part D paid
$31,118
Pharmacies billed $31,118 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
292 generic and fewer than 11 brand-name prescriptions · $31,118 in drug cost · 77 antibiotic prescriptions to 51 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 11 | $645 | $59 |
| Cefpodoxime Proxetil | 21 | $566 | $27 |
| Furosemide | 23 | $221 | $10 |
| Lisinopril | 19 | $192 | $10 |
| Losartan | 14 | $161 | $12 |
See all 9 drugs
| Amoxicillin-Clavulanate Potass | 11 | $645 | $59 |
| Cefpodoxime Proxetil | 21 | $566 | $27 |
| Furosemide | 23 | $221 | $10 |
| Lisinopril | 19 | $192 | $10 |
| Losartan | 14 | $161 | $12 |
| Pantoprazole | 11 | $119 | $11 |
| Amlodipine Besylate | 12 | $111 | $9 |
| Doxycycline Monohydrate | 11 | $99 | $9 |
| Prednisone | 14 | $83 | $6 |
Year by year
| 2024 | 368 | 123 | None | None | $31,118 |
| 2023 | 302 | 114 | None | None | $21,134 |
| 2022 | 306 | 117 | None | None | $24,760 |
| 2021 | 200 | 75 | None | 16% | $12,053 |
| 2020 | 273 | 88 | 4% (11) | 20% | $17,084 |
| 2019 | 215 | 77 | None | 17% | $9,186 |
| 2018 | 259 | 77 | None | None | $13,061 |
| 2017 | 405 | 128 | None | None | $30,885 |
| 2016 | 374 | 134 | None | None | $16,429 |
| 2015 | 320 | 118 | 4% (12) | None | $20,850 |
| 2014 | 393 | 135 | 6% (22) | None | $15,663 |
| 2013 | 286 | 99 | 7% (19) | None | $14,106 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Cefpodoxime Proxetil | 27 | $657 | $24 |
| Furosemide | 26 | $365 | $14 |
| Losartan | 18 | $214 | $12 |
| Amlodipine Besylate | 16 | $200 | $13 |
| Metoprolol | 16 | $131 | $8 |
| Spironolactone | 13 | $121 | $9 |
| Lisinopril | 12 | $114 | $10 |
| Doxycycline Monohydrate | 11 | $98 | $9 |
2022: 9 drugs
| Cefpodoxime Proxetil | 18 | $518 | $29 |
| Furosemide | 21 | $270 | $13 |
| Warfarin | 13 | $235 | $18 |
| Pantoprazole | 18 | $192 | $11 |
| Atorvastatin | 14 | $164 | $12 |
| Amlodipine Besylate | 13 | $144 | $11 |
| Doxycycline Monohydrate | 14 | $120 | $9 |
| Metoprolol | 13 | $100 | $8 |
| Losartan | 11 | $91 | $8 |
2021: 3 drugs
| Atorvastatin | 20 | $219 | $11 |
| Furosemide | 11 | $137 | $12 |
| Lisinopril | 12 | $123 | $10 |
2020: 6 drugs
| Cefpodoxime Proxetil | 15 | $320 | $21 |
| Furosemide | 21 | $225 | $11 |
| Warfarin | 13 | $192 | $15 |
| Atorvastatin | 15 | $172 | $11 |
| Doxycycline Monohydrate | 11 | $108 | $10 |
| Metoprolol | 15 | $107 | $7 |
2019: 6 drugs
| Atorvastatin | 11 | $132 | $12 |
| Furosemide | 14 | $126 | $9 |
| Amlodipine Besylate | 14 | $118 | $8 |
| Lisinopril | 12 | $111 | $9 |
| Doxycycline Monohydrate | 11 | $102 | $9 |
| Metoprolol | 11 | $85 | $8 |
2018: 4 drugs
| Furosemide | 32 | $262 | $8 |
| Warfarin | 16 | $167 | $10 |
| Lisinopril | 15 | $126 | $8 |
| Metoprolol | 13 | $96 | $7 |
2017: 9 drugs
| Humulin N | 17 | $2,211 | $130 |
| Warfarin | 33 | $383 | $12 |
| Clopidogrel | 12 | $273 | $23 |
| Atorvastatin | 12 | $258 | $21 |
| Furosemide | 24 | $250 | $10 |
| Lisinopril | 17 | $184 | $11 |
| Prednisone | 16 | $148 | $9 |
| Ciprofloxacin | 17 | $145 | $9 |
| Metoprolol | 17 | $125 | $7 |
2016: 6 drugs
| Warfarin | 31 | $374 | $12 |
| Hydralazine | 16 | $287 | $18 |
| Omeprazole | 12 | $287 | $24 |
| Furosemide | 26 | $281 | $11 |
| Cephalexin | 13 | $166 | $13 |
| Famotidine | 11 | $113 | $10 |
2015: 5 drugs
| Cefpodoxime Proxetil | 14 | $894 | $64 |
| Warfarin | 33 | $379 | $11 |
| Furosemide | 23 | $236 | $10 |
| Metoprolol | 17 | $143 | $8 |
| Ciprofloxacin | 12 | $138 | $11 |
2014: 10 drugs
| Atorvastatin | 15 | $353 | $24 |
| Nitrostat | 12 | $346 | $29 |
| Warfarin | 26 | $277 | $11 |
| Metoprolol | 28 | $264 | $9 |
| Ciprofloxacin | 20 | $182 | $9 |
| Lisinopril | 17 | $172 | $10 |
| Hydrocodone-Acetaminophen | 13 | $166 | $13 |
| Furosemide | 12 | $116 | $10 |
| Prednisone | 13 | $103 | $8 |
| Levofloxacin | 14 | $102 | $7 |
2013: 6 drugs
| Furosemide | 16 | $148 | $9 |
| Hydrocodone-Acetaminophen | 11 | $143 | $13 |
| Prednisone | 14 | $117 | $8 |
| Metoprolol | 14 | $97 | $7 |
| Lisinopril | 11 | $90 | $8 |
| Levofloxacin | 12 | $89 | $7 |
Professional record
- NPI
- 1194830828
- Licence
- WA ML20008379Washington MDRE.ML.20008379: Expired
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1959 Ne Pacific St, C212, Box 356340, Seattle, WA, 98195
- NPI first listed
- 2006-08-21
- NPI last updated
- 2021-12-14
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.